Recent multiomics analyses also suggested that groups of meningioma with multiple CNVs in addition to NF2 alterations tended to show poorer outcomes than a group of NF2‐altered meningioma without CNVs and a group of NF2‐intact meningioma.6, 26, 27. This evidence concerns the gene NF2 and meningioma.